您当前的位置:
首页 >
文章列表页 >
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials
- “在癌症三阴性治疗领域,近年来的研究取得了重大进展。专家们已经证实,靶向酪氨酸激酶(TKs)及其受体可以提供对抗TNBC的解决方案,为构建精准医学系统奠定了基础。”
- MMR 2025年12卷第8期 页码:1258-1282
DOI: 10.1186/s40779-024-00582-z
录用:2024-11-08
移动端阅览
AI导读
HTML全文
图( 4 ) 表( 3 )
参考文献
出版信息
数据统计
52
浏览量
40
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
Glycosylation as a design component of biomaterials in implant design
Toward phase contribution assessment in perioperative oncology: insights from NSCLC and a proposal for broader implementation
Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
相关作者
Ajaikumar B. Kunnumakkara
Gautam Sethi
Abhay Pandit
Ning Li
Da-Wei Wu
Ning Jiang
Yu Tang
Yan-Jie Han
相关机构
Rinn Medical Devices, University of Galway
Department of Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Health Management Center, the First Affiliated Hospital of Zhengzhou University
Shanghai Mobio Biomedical Technology Co., Ltd
Department of Breast Surgery, Affiliated Cancer Hospital of Zhengzhou University

